Rwanda is positioning its growing digital health and biomedical technology ecosystem as an investment opportunity for Singaporean companies. A two-week trade and investment mission, running from October 5 to 15, brings together 16 Singapore-based businesses operating in various sectors, including healthcare, digital technology, and artificial intelligence. This mission aims to deepen commercial relations and create new business partnerships between Rwanda and Singapore.
Senior officials from the Rwanda Food and Drugs Authority met with Dr. Suhina Singh, founder of Singapore-based health technology company Jonda Health, to discuss Rwanda's development priorities and potential areas for collaboration. Ministry of Health officials also held discussions with Dr. Irwan Moideen and Tita Adityaranie, co-founders of TI Medtech, focusing on potential investment, collaboration, and knowledge exchange around technology-enabled healthcare.
TI Medtech engaged with the University of Rwanda's Centre of Excellence in Biomedical Engineering and e-Health, discussing partnerships, investment, and knowledge transfer to accelerate healthcare innovation. This interest comes as Rwanda expands its health technology infrastructure, including the National Health Intelligence Center, launched in April 2025. The center integrates and analyzes real-time data from across the health system, developing technology-driven applications, including AI-supported clinical tools and telemedicine.
The National Health Intelligence Center's platform reports that a telemedicine pilot involving 51 health centers and four district hospitals resolved 93 percent of cases without referral during a 15-month pilot. Rwanda is seeking private investment in healthcare as part of its wider health-sector strategy, promoting investment in areas such as digital health workforce systems, health intelligence, and specialist healthcare.
The Kigali Health City is being positioned as a public-private investment platform for advanced healthcare, research, and medical tourism. The investment push is being reinforced by international financing, including $29.85 million approved by the African Development Bank in January 2026 for the second phase of Rwanda's Centre of Excellence for Biomedical Engineering and e-Health project.
Rwanda has also been selected to test AI-powered healthcare technology in over 50 health clinics under the Horizons1000 initiative backed by the Gates Foundation and OpenAI. This initiative highlights Rwanda's ambitions to use artificial intelligence and digital tools to address healthcare access and workforce challenges. The Singapore mission is expected to generate investment projects, commercial partnerships, and technology and knowledge-transfer opportunities.
Rwanda and Singapore already have an established cooperation framework covering areas such as ICT, cybersecurity, and human-capital development. The current mission is expected to strengthen this cooperation, with healthcare and technology emerging as important areas of potential cooperation between the two countries.
Key points
- Rwanda seeks to attract Singaporean investment in its growing digital health and biomedical technology ecosystem.
- The two-week trade and investment mission brings together 16 Singapore-based businesses operating in various sectors.
- Rwanda has been selected to test AI-powered healthcare technology in over 50 health clinics under the Horizons1000 initiative.
